Human Glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 G93A mouse model of ALS

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Lepore, Angelo C ^a   O'Donnell, John ^b   Kim, Andrew S ^b   Williams, Timothy ^b   Tuteja, Alicia ^b   Rao, Mahendra S ^c,e   Kelley, Linda L ^d   Campanelli, James T ^e,f   Maragakis, Nicholas J ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Life Technologies   (United States)

^d UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^e Q Therapeutics   (United States)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; CYCLOSPORIN; RAPAMYCIN; SUPEROXIDE DISMUTASE; TACROLIMUS;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL DIFFERENTIATION; CELL MIGRATION; CELL SURVIVAL; CERVICAL SPINAL CORD; CONTROLLED STUDY; DISEASE COURSE; FETUS; GLIAL RESTRICTED PROGENITOR; GRAY MATTER; HUMAN; HUMAN CELL; IN VIVO STUDY; MOTONEURON; MOUSE; NEUROPROTECTION; NONHUMAN; SAFETY; STEM CELL; STEM CELL TRANSPLANTATION; TREATMENT RESPONSE; WHITE MATTER; ANIMAL; ANTERIOR HORN CELL; CELL PROLIFERATION; CERVICAL SPINE; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; FEMALE; GENETICS; GLIA; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MALE; METHODOLOGY; MUTATION; NERVE CELL; OLIGODENDROGLIA; PATHOLOGY; PREGNANCY; SPINAL CORD;

MUS; RATTUS; RODENTIA;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANTERIOR HORN CELLS; ASTROCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CERVICAL VERTEBRAE; CYCLOSPORINE; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOSUPPRESSION; MALE; MICE; MUTATION; NEUROGLIA; NEURONS; OLIGODENDROGLIA; PREGNANCY; SIROLIMUS; SPINAL CORD; STEM CELL TRANSPLANTATION; STEM CELLS; SUPEROXIDE DISMUTASE; TACROLIMUS;

EID: 80053608707     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025968     Document Type: Article

References (39)

1. Bruijn LI, Miller TM, Cleveland DW, (2004) Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 27: 723-749.
2. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62.
3. Bruijn LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, et al. (1997) ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18: 327-338.
4. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, et al. (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264: 1772-1775.
5. Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, et al. (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14: 1105-1116.
6. Howland DS, Liu J, She Y, Goad B, Maragakis NJ, et al. (2002) Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci U S A 99: 1604-1609.
7. Matsumoto A, Okada Y, Nakamichi M, Nakamura M, Toyama Y, et al. (2006) Disease progression of human SOD1 (G93A) transgenic ALS model rats. J Neurosci Res 83: 119-133.
8. Nagai M, Aoki M, Miyoshi I, Kato M, Pasinelli P, et al. (2001) Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. J Neurosci 21: 9246-9254.
9. Ilieva H, Polymenidou M, Cleveland DW, (2009) Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol 187: 761-772.
10. Pekny M, Nilsson M, (2005) Astrocyte activation and reactive gliosis. Glia 50: 427-434.
11. Maragakis NJ, Rothstein JD, (2006) Mechanisms of Disease: astrocytes in neurodegenerative disease. Nat Clin Pract Neurol 2: 679-689.
12. Rothstein JD, Martin LJ, Kuncl RW, (1992) Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 326: 1464-1468.
13. Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW, (1995) Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 38: 73-84.
14. Clement AM, Nguyen MD, Roberts EA, Garcia ML, Boillee S, et al. (2003) Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302: 113-117.
15. Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, et al. (2008) Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11: 251-253.
16. Lepore AC, Rauck B, Dejea C, Pardo AC, Rao MS, et al. (2008) Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat Neurosci 11: 1294-1301.
17. Haverkamp LJ, Appel V, Appel SH, (1995) Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 118 (Pt 3): 707-719.
18. Mitsumoto H, Chad DA, Pioro EP, (1998) Amyotrophic lateral sclerosis. Philadelphia F.A. Davis. xxv, 480 p. p.
19. Lepore AC, Tolmie C, O'Donnell J, Wright MC, Dejea C, et al. (2010) Peripheral hyperstimulation alters site of disease onset and course in SOD1 rats. Neurobiol Dis 39: 252-264.
20. Llado J, Haenggeli C, Pardo A, Wong V, Benson L, et al. (2006) Degeneration of respiratory motor neurons in the SOD1 G93A transgenic rat model of ALS. Neurobiol Dis 21: 110-118.
21. Campanelli JT, Sandrock RW, Wheatley W, Xue H, Zheng J, et al. (2008) Expression profiling of human glial precursors. BMC Dev Biol 8: 102.
22. Sandrock RW, Wheatley W, Levinthal C, Lawson J, Hashimoto B, et al. (2010) Isolation, characterization and preclinical development of human glial-restricted progenitor cells for treatment of neurological disorders. Regen Med 5: 381-394.
23. Lepore AC, Dejea C, Carmen J, Rauck B, Kerr DA, et al. (2008) Selective ablation of proliferating astrocytes does not affect disease outcome in either acute or chronic models of motor neuron degeneration. Exp Neurol 211: 423-432.
24. Lepore AC, Haenggeli C, Gasmi M, Bishop KM, Bartus RT, et al. (2007) Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALS. Brain Res 1185: 256-265.
25. Lepore AC, Fischer I, (2005) Lineage-restricted neural precursors survive, migrate, and differentiate following transplantation into the injured adult spinal cord. Exp Neurol 194: 230-242.
26. Lepore AC, Neuhuber B, Connors TM, Han SS, Liu Y, et al. (2006) Long-term fate of neural precursor cells following transplantation into developing and adult CNS. Neuroscience 142: 287-304.
27. Han SS, Kang DY, Mujtaba T, Rao MS, Fischer I, (2002) Grafted lineage-restricted precursors differentiate exclusively into neurons in the adult spinal cord. Exp Neurol 177: 360-375.
28. Papadeas ST, Maragakis NJ, (2009) Advances in stem cell research for Amyotrophic Lateral Sclerosis. Curr Opin Biotechnol 20: 545-551.
29. Maragakis NJ, Dietrich J, Wong V, Xue H, Mayer-Proschel M, et al. (2004) Glutamate transporter expression and function in human glial progenitors. Glia 45: 133-143.
30. Walczak P, All AH, Rumpal N, Gorelik M, Kim H, et al. (2011) Human glial-restricted progenitors survive, proliferate, and preserve electrophysiological function in rats with focal inflammatory spinal cord demyelination. Glia 59: 499-510.
31. Yan J, Xu L, Welsh AM, Chen D, Hazel T, et al. (2006) Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice. Stem Cells 24: 1976-1985.
32. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
33. Zhao T, Zhang ZN, Rong Z, Xu Y, (2011) Immunogenicity of induced pluripotent stem cells. Nature 474: 212-215.
34. Chandran S, Compston A, Jauniaux E, Gilson J, Blakemore W, et al. (2004) Differential generation of oligodendrocytes from human and rodent embryonic spinal cord neural precursors. Glia 47: 314-324.
35. Ray J, Gage FH, (2006) Differential properties of adult rat and mouse brain-derived neural stem/progenitor cells. Mol Cell Neurosci 31: 560-573.
36. Suzuki M, McHugh J, Tork C, Shelley B, Klein SM, et al. (2007) GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS One 2: e689.
37. Park S, Kim HT, Yun S, Kim IS, Lee J, et al. (2009) Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice. Exp Mol Med 41: 487-500.
38. Lepore AC, Maragakis NJ, (2007) Targeted stem cell transplantation strategies in ALS. Neurochem Int 50: 966-975.
39. Xu L, Shen P, Hazel T, Johe K, Koliatsos VE, (2011) Dual transplantation of human neural stem cells into cervical and lumbar cord ameliorates motor neuron disease in SOD1 transgenic rats. Neurosci Lett 494: 222-226.